ArticleGastroenterology report2024

HLA-DQA1*05 correlates with increased risk of anti-drug antibody development and reduced response to infliximab in Chinese patients with Crohn's disease.

Wei Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.